Gupta VK. Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye. J Neurosci Neurol Disord [Internet]. 2023 Nov. 9 [cited 2025 Oct. 10];7(2):134-5. Available from: https://www.neuroscijournal.com/jnnd/article/view/jnnd-aid1087